Editorial: the microscope holds the key to predict need for biologic therapy in immunotherapy‐checkpoint inhibitor colitis

LINKED CONTENT This article is linked to Pai et al papers. To view these articles, visit https://doi.org/10.1111/apt.16142 and https://doi.org/10.1111/apt.16245